Skip to content

Myasthenia Gravis - Utilising Cross Platform Quantitative Content Analysis to uncover and validate the unmet needs of Myasthenia patients

Myasthenia Gravis - Utilising Cross Platform Quantitative Content Analysis to uncover and validate the unmet needs of Myasthenia patients - MG – CroPlat

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028999
Enrollment
3000
Registered
2023-02-06
Start date
2023-03-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G70.0

Interventions

Group 1: Posts by patients with myasthenia gravis in Facebook groups are analysed for content category.

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: age = 18

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
The main objective of this study is to categorise questions that users of Facebook groups ask other users about MG. For this purpose, the frequencies of question categories and subcategories are examined as a surrogate for unmet needs.

Secondary

MeasureTime frame
The secondary aim of this study is to compare and link the frequency of question categories with other parameters (such as author category, see below) posted in different Facebook groups in order to validate the relevance and authenticity of queries in relation to the broader MG population. For this, the queries posted in multiple Facebook groups will be examined for: - Author categories [diagnosed MG; previously undiagnosed/confirmed MG; unknown; patient's friend/family; professional (including physicians)] - User categories (users with one-time contributions, users with more frequent contributions and so-called "superusers"). - Gender.

Countries

Germany

Contacts

Public ContactSophie Lehnerer

Charité Universitätsmedizin Berlin

sophie.lehnerer@charite.de+4930450539734

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026